Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tremor | 3 | 2021 | 136 | 1.410 |
Why?
|
| Dystonia | 5 | 2023 | 173 | 1.270 |
Why?
|
| Dystonic Disorders | 3 | 2023 | 94 | 1.030 |
Why?
|
| Movement Disorders | 3 | 2022 | 223 | 0.890 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2023 | 14 | 0.830 |
Why?
|
| Brain Diseases | 2 | 2022 | 308 | 0.750 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2021 | 164 | 0.700 |
Why?
|
| Migraine with Aura | 1 | 2021 | 16 | 0.690 |
Why?
|
| Chorea | 1 | 2021 | 39 | 0.690 |
Why?
|
| Hemiplegia | 1 | 2021 | 43 | 0.680 |
Why?
|
| Jaw Diseases | 1 | 2020 | 3 | 0.680 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2021 | 71 | 0.670 |
Why?
|
| Tics | 1 | 2021 | 49 | 0.660 |
Why?
|
| Neuromuscular Agents | 1 | 2020 | 66 | 0.630 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 749 | 0.610 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3853 | 0.360 |
Why?
|
| Botulinum Toxins | 2 | 2023 | 122 | 0.330 |
Why?
|
| Phenotype | 3 | 2024 | 4540 | 0.220 |
Why?
|
| Receptors, AMPA | 1 | 2024 | 50 | 0.210 |
Why?
|
| Infant | 5 | 2024 | 13049 | 0.210 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2023 | 13 | 0.210 |
Why?
|
| Tic Disorders | 1 | 2024 | 78 | 0.200 |
Why?
|
| Myoclonus | 1 | 2023 | 32 | 0.200 |
Why?
|
| Gain of Function Mutation | 1 | 2024 | 111 | 0.200 |
Why?
|
| Loss of Function Mutation | 1 | 2024 | 160 | 0.200 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2022 | 19 | 0.190 |
Why?
|
| Self-Injurious Behavior | 1 | 2023 | 66 | 0.190 |
Why?
|
| Niacin | 1 | 2022 | 59 | 0.190 |
Why?
|
| Levodopa | 1 | 2021 | 94 | 0.180 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 78 | 0.180 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2021 | 18 | 0.170 |
Why?
|
| Child, Preschool | 6 | 2024 | 14736 | 0.170 |
Why?
|
| Iron | 1 | 2023 | 302 | 0.170 |
Why?
|
| Muscle Contraction | 1 | 2021 | 154 | 0.170 |
Why?
|
| Humans | 16 | 2024 | 132247 | 0.150 |
Why?
|
| Meningitis, Viral | 1 | 2018 | 10 | 0.150 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2018 | 12 | 0.150 |
Why?
|
| Myelitis | 1 | 2018 | 15 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2024 | 554 | 0.140 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 50 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2018 | 142 | 0.140 |
Why?
|
| Larynx | 1 | 2018 | 75 | 0.130 |
Why?
|
| West Nile virus | 1 | 2018 | 117 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 139 | 0.130 |
Why?
|
| Pedigree | 1 | 2020 | 1724 | 0.130 |
Why?
|
| Chromosome Disorders | 1 | 2018 | 311 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2023 | 1094 | 0.120 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 656 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 299 | 0.110 |
Why?
|
| Male | 7 | 2024 | 65012 | 0.110 |
Why?
|
| Brain | 2 | 2023 | 3194 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 1037 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 540 | 0.100 |
Why?
|
| Child | 7 | 2024 | 25783 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2021 | 13027 | 0.100 |
Why?
|
| Mutation | 2 | 2023 | 6250 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2010 | 317 | 0.070 |
Why?
|
| Female | 6 | 2024 | 70785 | 0.060 |
Why?
|
| Qb-SNARE Proteins | 1 | 2023 | 6 | 0.050 |
Why?
|
| Amines | 1 | 2022 | 37 | 0.050 |
Why?
|
| Injections | 1 | 2023 | 152 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2023 | 58 | 0.050 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2022 | 17 | 0.050 |
Why?
|
| Epilepsy | 1 | 2010 | 891 | 0.050 |
Why?
|
| Adolescent | 4 | 2024 | 20557 | 0.050 |
Why?
|
| Ataxia | 1 | 2023 | 177 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 242 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2021 | 196 | 0.040 |
Why?
|
| Pediatrics | 1 | 2010 | 1210 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 398 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2021 | 463 | 0.040 |
Why?
|
| Seizures | 1 | 2023 | 895 | 0.040 |
Why?
|
| Rats | 1 | 2022 | 3607 | 0.030 |
Why?
|
| Syndrome | 1 | 2018 | 1175 | 0.030 |
Why?
|
| Young Adult | 2 | 2024 | 9966 | 0.030 |
Why?
|
| California | 1 | 2010 | 140 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 333 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 17395 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 31614 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2010 | 390 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 1444 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 34850 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2010 | 3139 | 0.010 |
Why?
|